Document ID: chunk:federal_register_of_legislation:F2024C00208:reg:9:p5
Version: federal_register_of_legislation:F2024C00208
Segment Type: reg
Provision Reference: reg 9 (pt 5/5)
Character Range: 16615–18956

Note: smokeless tobacco is defined in the Schedule 1 – Dictionary.
(31)      inhaling opium smoke or ingesting opium on average at least weekly for at least 10 years before the clinical onset of malignant neoplasm of the lung;
Note: opium is defined in the Schedule 1 – Dictionary.
(32)      using manual welding equipment for welding metal:
(a)          for a cumulative period of at least 1,500 hours before the clinical onset of malignant neoplasm of the lung; and
(b)          where that use began at least 5 years before the clinical onset of malignant neoplasm of the lung;
(33)      being exposed to benzene as specified:
(a)          for a cumulative total of at least 2,500 hours within a continuous period of 5 years before the clinical onset of malignant neoplasm of the lung; and
(b)          where the first exposure in that period occurred at least 5 years before the clinical onset of malignant neoplasm of the lung;
Note: being exposed to benzene as specified is defined in the Schedule 1 – Dictionary.
(34)      being exposed to benzene:
(a)          in an amount greater than 10 ppm-years of cumulative exposure before the clinical onset of malignant neoplasm of the lung; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of  malignant neoplasm of the lung;
Note: ppm-years is defined in the Schedule 1 – Dictionary.
(35)      taking a Janus kinase inhibitor on more days than not for at least 6 months before the clinical onset of malignant neoplasm of the lung;
Note: Janus kinase inhibitors include abrocitinib, filgotinib, baricitinib, upadacitinib and tofacitinib and are used in the treatment of chronic inflammatory disorders (rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, ulcerative colitis, atopic dermatitis and alopecia areata).
(36)      for lymphoepithelial carcinoma of the lung, having infection with the Epstein-Barr virus before the clinical onset of malignant neoplasm of the lung;
Note: Lymphoepithelial carcinoma of the lung is a rare poorly differentiated squamous cell carcinoma admixed with variable amounts of lymphoplasmacytic infiltrate.
(37)      inability to obtain appropriate clinical management for malignant neoplasm of the lung before the clinical worsening of malignant neoplasm of the lung.